Optical coherence tomography is less sensitive than visual evoked potentials in optic neuritis

Neurology

Volumn 73, Issue 1, 2009, Pages 46-52

  Naismith, R T ^a,c   Tutlam, N T ^a   Xu, J ^a   Shepherd, J B ^b   Klawiter, E C ^a   Song, S K ^b   Cross, A H ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY   (United States)

^c Neurology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID;

ADULT; AGED; ARTICLE; CONTRAST SENSITIVITY; CROSS-SECTIONAL STUDY; DISEASE MARKER; DISEASE SEVERITY; ETHNICITY; EVOKED VISUAL RESPONSE; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; NERVE FIBER; ONSET AGE; OPTIC NERVE; OPTIC NEURITIS; OPTICAL COHERENCE TOMOGRAPHY; PREDICTOR VARIABLE; PRIORITY JOURNAL; RECURRENT DISEASE; RETINA NERVE CELL; SEX DIFFERENCE; THICKNESS; VISION; VISUAL ACUITY;

EID: 68249149190     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181aaea32     Document Type: Article

References (38)

1. Huang D, Swanson EA, Lin CP, et al. Optical coherence tomography. Science 1991;254:1178-1181.
2. Toth CA, Narayan DG, Boppart ST, et al. A comparison of retinal morphology viewed by optical coherence tomography and by light microscopy. Arch Ophthalmol 1997;115:1425-1428.
3. Chen TC, Cense B, Miller JW, et al. Histologic correlation of in vivo optical coherence tomography images of the human retina. Am J Ophthalmol 2006;141:1165-1168.
4. Yucel YH, Gypta N, Kalichman MW, et al. Relationship of optic disc topography to optic nerve fiber number in glaucoma. Arch Opthalmol 1998;116:493-497.
5. Costello F, Hodge W, Pan Y, Eggenberger E, Coupland S, Kardon RH. Tracking retinal nerve fiber layer loss after optic neuritis: a prospective study using optical coherence tomography. Mult Scler 2008;14:893-905.
6. Kerrison JB, Flynn T, Green R. Retinal pathologic changes in multiple sclerosis. Retina 1994;14:445-451.
7. Elbol P, Work K. Retinal nerve fiber layer in multiple sclerosis. Acta Ophthalmol 1990;68:481-486.
8. Frisen LF, Boyt WF. Insidious atrophy of retinal nerve fibers in multiple sclerosis. Arch Opthalmol 1974;92:91-97.
9. Naismith RT, Tutlam NT, Xu J, et al. Optical coherence tomography differs in neuromyelitis optica compared with multiple sclerosis. Neurology 2009;72:1077-1082.
10. Naismith RT, Xu J, Tutlam NT, et al. Disability in optic neuritis correlates with diffusion tensor-derived directional diffusivities. Neurology 2009;72:589-594.
11. Fisher JB, Jacobs DA, Markowitz CE, et al. Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. Ophthalmology 2006;113:324-332.
12. Steel DH, Waldock A. Measurement of the retinal nerve fibre layer with the scanning laser polarimetry in patients with previous demyelinating optic neuritis. J Neurol Neurosurg Psychiatry 1998;64:505-509.
13. Pulicken M, Gordon-Lipkin E, Balcer LJ, Frohman E, Cutter G, Calabresi PA. Optical coherence tomography and disease subtype in multiple sclerosis. Neurology 2007;69:2085-2092.
14. Pueyo V, Martin J, Fernandez J, et al. Axonal loss in the retinal nerve fiber layer in patients with multiple sclerosis. Mult Scler 2008;14:609-614.
15. Costello F, Coupland S, Hodge W, et al. Quantifying axonal loss after optic neuritis with optical coherence tomography. Ann Neurol 2006;59:963-969.
16. Gordon-Lipkin E, Chodkowski B, Reich DS, et al. Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis. Neurology 2007;69:1603-1609.
17. Sepulcre J, Murie-Fernandez M, Salinas-Alaman A, Garcia-Layana A, Bejarano B, Villoslada P. Diagnostic accuracy of retinal abnormalities in predicting disease activity in MS. Neurology 2007;68:1488-1494.
18. Budenz DL, Anderson DR, Varma R, et al. Determinants of normal retinal nerve fiber layer thickness measured by Stratus OCT. Ophthalmology 2007;114:1046-1052.
19. Resolution Adopted by the International Council of Ophthalmology, Sydney, Australia, April 20, 2002. Available at: www.icoph.org/pdf/visualstanres.pdf. Accessed May 7, 2009.
20. Fredrikson JL, Petrera J. Serial visual evoked potentials in 90 untreated patients with acute optic neuritis. Surv Ophthalmol 1999;44(suppl 1):S54-S62.
21. Beck RW, Cleary PA, Anderson MM, et al. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. N Engl J Med 1991;326:581-588.
22. Balcer LJ, Baier ML, Kunkle AM, et al. Self-reported visual dysfunction in multiple sclerosis: results from the 25-item national eye institute visual function questionnaire. Mult Scler 2000;6:382-385.
23. Ma SL, Shea JA, Galetta SL, et al. Self-reported visual dysfunction in multiple sclerosis: new data from the VFQ-25 and development of an MS-specific vision questionnaire. Am J Ophthalmol 2002;133:686.
24. Rudick RA, Miller D, Clough JD, Gragg LA, Farmer RG. Quality of life in multiple sclerosis. Comparisons with inflammatory bowel disease and rheumatoid arthritis. Arch Neurol 1992;49:1237-1242.
25. Jacobs LD, Beck RW, Simon JH, et al. Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group. N Engl J Med 2000;343:898-904.
26. Comi G, Filippi M, Barkhof F, et al. Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study. Lancet 2001;357:1576-1582.
27. Kappos L, Polman CH, Freedman MS, et al. Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes. Neurology 2006;67:1242-1249.
28. Ogden TE. Nerve fiber layer of the primate retina: thickness and glial content. Vision Res 1983;23:581-587.
29. Chan CK, Miller NR. Peripapillary nerve fiber layer thickness measured by optical coherence tomography in patients with no light perception from long-standing nonglaucomatous optic neuropathies. J Neuroophthalmol 2007;27:176-179.
30. Weinshenker BG, Rice GPA, Noseworthy JH, Carriere W, Baskerville J, Ebers GC. The natural history of multiple sclerosis: a geographically based study, 3: multivariate analysis of predictive factors and models of outcome. Brain 1991;114:1045-1056.
31. Naismith RT, Trinkaus K, Cross AH. Phenotype and prognosis in African-Americans with multiple sclerosis: a retrospective chart review. Mult Scler 2006;12:775-781.
32. Brusa A, Jones SJ, Plant GT. Long term remyelination after optic neuritis: a 2-year visual evoked potential and psychophysical serial study. Brain 2001;124:468-479.
33. Klistorner A, Arvind H, Nguyen T, et al. Axonal loss and myelin in early ON loss in postacute optic neuritis Ann Neurol 2008;64:325-331.
34. Trip SA, Schlottmann PG, Jones SJ, et al. Retinal nerve fiber layer loss and visual dysfunction in optic neuritis. Ann Neurol 2005;58:383-391.
35. Trip SA, Schlottmann PG, Jones SJ, et al. Optic nerve atrophy and retinal nerve fibre layer thinning following optic neuritis: evidence that axonal loss is a substrate of MRI-detected atrophy. Neuroimage 2006;31:286-293.
36. Vedula A, Brodney-Folse S, Gal R, Beck R. Corticosteroids for treating optic neuritis. Cochrane Database System Rev 2007;(1):CD001430.
37. Roxburgh RHSR, Seaman SR, Masterman T, et al. Multiple sclerosis severity score. Neurology 2005;64:1144-1151.
38. Mantyjarvi M, Laitinen T. Normal values for the Pelli-Robson contrast sensitivity test. J Cataract Refract Surg 2001;27:261-266.